Schumacher, S. M., Gao, E., Zhu, W., Chen, X., Chuprun, J. K., Feldman, A. M., … Koch, W. J. (2015). Paroxetine-Mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling After Myocardial Infarction. In Journal of Cardiac Failure (Vol. 21, pp. S109–S109). Elsevier BV. https://doi.org/10.1016/j.cardfail.2015.06.318

Schumacher, Sarah M., Erhe Gao, Weizhong Zhu, Xiongwen Chen, J Kurt Chuprun, Arthur M. Feldman, John J. G. Tesmer, and Walter J. Koch. “Paroxetine-Mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling After Myocardial Infarction.” In Journal of Cardiac Failure, 21:S109–S109. Elsevier BV, 2015. https://doi.org/10.1016/j.cardfail.2015.06.318.

Schumacher SM, Gao E, Zhu W, Chen X, Chuprun JK, Feldman AM, et al. Paroxetine-Mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling After Myocardial Infarction. In: Journal of Cardiac Failure. Elsevier BV; 2015. p. S109–S109.

Schumacher, Sarah M., et al. “Paroxetine-Mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling After Myocardial Infarction.” Journal of Cardiac Failure, vol. 21, no. 8, Elsevier BV, 2015, pp. S109–S109. Crossref, doi:10.1016/j.cardfail.2015.06.318.

Schumacher SM, Gao E, Zhu W, Chen X, Chuprun JK, Feldman AM, Tesmer JJG, Koch WJ. Paroxetine-Mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling After Myocardial Infarction. Journal of Cardiac Failure. Elsevier BV; 2015. p. S109–S109.